Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2021 Sep 8;30(11):2079–2087. doi: 10.1158/1055-9965.EPI-21-0400

Table 4.

CpGs showing consistent direction of effect for directly measured levels in pancreas tumor versus benign tissues and genetically predicted levels in blood of pancreatic cancer cases versus controls

CpG site Chr Position Direction of association between genetically predicted levels and pancreatic cancer risk Average levels in benign pancreatic tissue Standard deviation of levels in benign pancreatic tissue Average levels in pancreatic tumor tissue Standard deviation of levels in pancreatic tumor tissue P value comparing levels in pancreas tumor versus benign tissue
cg17804356 1 200009927 + 0.02 0.04 0.12 0.15 <0.0004
cg20930114 2 110372285 + 0.005 0.02 0.04 0.05 0.0004
cg07380026 5 1296007 + 0.24 0.18 0.54 0.20 <0.0004
cg01169778 9 136038690 + 0.23 0.11 0.46 0.29 0.01
cg22535403 9 136150032 + 0.35 0.21 0.48 0.28 0.05
cg21101465 13 28493404 0.36 0.19 0.27 0.22 0.02